Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Schistosomiasis vaccine development--the current picture

G J Waine1, D P McManus

  • 1Molecular Parasitology Unit, Queensland Institute of Medical Research, Australia. garyW@qimr.edu.au

Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology
|May 1, 1997
PubMed
Summary

Developing a human vaccine for schistosomiasis is a global health priority. This review explores feasible, safe vaccine approaches beyond attenuated options for this widespread parasitic disease.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Analysis of the cox1 gene in Echinococcus granulosus from sheep in northeast Iran using PCR high-resolution melting (qPCR-HRM) curve analysis.

Tropical biomedicine·2021
Same author

Surgical treatment of hepatic cystic echinococcosis in patients co-infected with HIV/AIDS.

Journal of helminthology·2015
Same author

Immunodiagnosis of sheep infections with Echinococcus granulosus: in 35 years where have we come?

Parasite immunology·2013
Same author

Current status of the genetics and molecular taxonomy of Echinococcus species.

Parasitology·2013
Same author

Novel immunomic technologies for schistosome vaccine development.

Parasite immunology·2012
Same author

SerpinB2 deficiency modulates Th1⁄Th2 responses after schistosome infection.

Parasite immunology·2010

Area of Science:

  • Parasitology
  • Vaccinology
  • Global Health

Background:

  • Schistosomiasis affects over 200 million people globally.
  • The World Health Organization prioritizes schistosomiasis vaccine development.
  • Natural immunity in humans and successful animal vaccines suggest feasibility.

Purpose of the Study:

  • To review progress in developing a safe and effective human vaccine for schistosomiasis.
  • To explore alternative vaccine strategies beyond attenuated approaches.

Main Methods:

  • Literature review of current research areas.
  • Analysis of scientific progress towards vaccine development.

Main Results:

  • Attenuated vaccines are not suitable for human schistosomiasis treatment.

Related Experiment Videos

  • Multiple research avenues are being explored for vaccine candidates.

    • Conclusions:

    • Achieving a safe and effective human schistosomiasis vaccine requires exploring diverse strategies.
    • Continued research is essential to overcome challenges in vaccine development.